U.S., Nov. 26 -- An application to own the trademark for 'ANAKA PHARMA' has been filed on Apr. 07, 2025.
Owner(s):
Anaka Pharmaceuticals, Inc.; 21 Seaborn Place, , MASSACHUSETTS
Goods and/or Services:
For: Small molecule therapeutic pharmaceuticals for the treatment of neurodevelopmental disorders, namely, attention deficit hyperactivity disorder (ADHD), autism spectrum disorders, and Down syndrome
Class(es): 005, 006, 018, 044, 046, 051, 052
For: Pharmaceutical research and development for neurodevelopment disorders
Class(es): 100, 101
Mark Drawing Type: 3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)
https://eog-tmng.uspto.gov/#/issueDate=2025-11-25&serialNumber=99123382
Disclaimer: Curated by HT Syndication....